Immune Pharmaceutical (IMNPQ) Stock Goes Parabolic: What’s The Buzz?

The Immune Pharmaceutical (OTC: IMNPQ) stock has emerged as one of the biggest gainers in recent weeks and perhaps it is time for investors to take a closer look at the company.

On Monday, the Immune Pharmaceutical stock soared by as high as 100% to continue its remarkable rally that started in the middle of last month. Since mid-March, the Immune stock has rallied strongly and delivered gains of 900%. Back on March 18, it emerged that the company was in preliminary discussions with the United Kingdom-based investment firm United General Ltd with regards to a restructuring.

Related:  2 Breakout Biotech Stocks: Ardelyx (ARDX), BioCryst Pharmaceuticals (BCRX)

At this point in time, the company’s trustees as well as other representatives are looking for different options with regards to a restructuring of the company. In addition to that, United General has also pointed out that interest has emerged with regards to the possible acquisition of Immune. These developments have led to considerable optimism among investors with regard to the stock.

Jack Dawkins

Finance and Tech Contributor